Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
The gut microbiota influences blood-brain barrier permeability in mice
2014 Standout
The NMDA and AMPA/KA Receptors are Involved in Glutamate-Induced Alterations of Occludin Expression and Phosphorylation in Brain Endothelial Cells
2007
Pericytes from Brain Microvessels Strengthen the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells
2007
TEER Measurement Techniques for In Vitro Barrier Model Systems
2015 Standout
Brain membrane lipids in major depression and anxiety disorders
2014
Astrocytes: biology and pathology
2009 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Pericytes are required for blood–brain barrier integrity during embryogenesis
2010 StandoutNature
2′-O Methylation of the Viral mRNA Cap by West Nile Virus Evades Ifit1-Dependent and -Independent Mechanisms of Host Restriction In Vivo
2012
Sjögren's syndrome
2005 Standout
Lipopolysaccharide alters the blood–brain barrier transport of amyloid β protein: A mechanism for inflammation in the progression of Alzheimer’s disease
2009
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Snake bite
2010
Regulation of major efflux transporters under inflammatory conditions at the blood‐brain barrierin vitro
2009
Changes in Lipidome Composition during Brain Development in Humans, Chimpanzees, and Macaque Monkeys
2017 StandoutNobel
Structure and function of the blood–brain barrier
2009 Standout
Oral Anticoagulant Therapy
2012 Standout
Lipopolysaccharide-Activated Microglia Induce Dysfunction of the Blood–Brain Barrier in Rat Microvascular Endothelial Cells Co-Cultured with Microglia
2009
An Improved In Vitro Blood–Brain Barrier Model: Rat Brain Endothelial Cells Co-cultured with Astrocytes
2011
TFOS DEWS II Diagnostic Methodology report
2017 Standout
Nanofiltration of plasma‐derived biopharmaceutical products
2003
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome
2016 Standout
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes
2008 Standout
Ligand Binding by Antibody IgE Lb4: Assessment of Binding Site Preferences Using Microcalorimetry, Docking, and Free Energy Simulations
1999
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Snakebite envenoming
2017 Standout
Lipopolysaccharide impairs amyloid beta efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood–brain barrier
2012
A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease
2008
Neurological Involvement in Primary Sjögren Syndrome: A Focus on Central Nervous System
2014
Murine in vitro model of the blood–brain barrier for evaluating drug transport
2010
Identifying blood-brain-barrier selective single-chain antibody fragments
2014
Aptamers as therapeutics
2010 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
Is docosahexaenoic acid, an n−3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals
2005
Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier
2010
Intrinsic Immunity Shapes Viral Resistance of Stem Cells
2017 StandoutNobel
To translate, or not to translate: viral and host mRNA regulation by interferon-stimulated genes
2015 StandoutNobel
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Fish Intake, Contaminants, and Human Health
2006 Standout
Trends in Snakebite Envenomation Therapy: Scientific, Technological and Public Health Considerations
2007
Use of Muscarinic Agonists in the Treatment of Sjögren's Syndrome
2001
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Microfluidic organs-on-chips
2014 Standout
Growth-factor reduced Matrigel source influences stem cell derived brain microvascular endothelial cell barrier properties
2016
Docosahexaenoic acid in the diet: its importance in maintenance and restoration of neural membrane function
2004
Allometric scaling of xenobiotic clearance: Uncertainty versus universality
2001
Fab Antibody Fragments
2004
Subcutaneous and visceral adipose tissue: structural and functional differences
2009 Standout
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention
2009
Pericyte–endothelial cell interaction increases MMP-9 secretion at the blood–brain barrier in vitro
2007
The Influence of Exercise on Cognitive Abilities
2012 Standout
The effect of astrocytes on the induction of barrier properties in aortic endothelial cells
2011
Differentiating embryonic neural progenitor cells induce blood–brain barrier properties
2006
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitromodels of the rat blood-brain barrier and blood-spinal cord barrier
2013
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Computational design of ligand-binding proteins with high affinity and selectivity
2013 StandoutNatureNobel
Peripheral Nerve pericytes originating from the blood–nerve barrier expresses tight junctional molecules and transporters as barrier‐forming cells
2008
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Colloidal gold conjugated monoclonal antibodies, studied in the BIAcore biosensor and in the Nycocard immunoassay format
1995
Solution structure of an informationally complex high-affinity RNA aptamer to GTP
2006 StandoutNobel
Evolution of aptamers with a new specificity and new secondary structures from an ATP aptamer
2003 StandoutNobel
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs
2011
Functional Nucleic Acid Sensors
2009 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Interendothelial Claudin-5 Expression Depends on Cerebral Endothelial Cell–Matrix Adhesion by β1-Integrins
2011
Water as an Active Constituent in Cell Biology
2007 Standout
In Vitro Models of the Blood–Brain Barrier for the Study of Drug Delivery to the Brain
2014
Testing the Neurovascular Hypothesis of Alzheimer's Disease: LRP-1 Antisense Reduces Blood-brain Barrier Clearance, Increases Brain Levels of Amyloid-β Protein, and Impairs Cognition
2009
The Triterpenoid Betulin Protects against the Neuromuscular Effects ofBothrops jararacussuSnake VenomIn Vivo
2015 Standout
1,500 scientists lift the lid on reproducibility
2016 StandoutNature
Neurological Symptoms in Type A Aortic Dissections
2006
Pharmacokinetics of Coagulation Factors
2001
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
Pharmacokinetic-Pharmacodynamic Relationships of Immunoglobulin Therapy for Envenomation
2003
Impairment of paravascular clearance pathways in the aging brain
2014 Standout
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
[Metabolic difference between visceral fat and subcutaneous abdominal fat].
2000
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
RNA Aptamers to S-Adenosylhomocysteine: Kinetic Properties, Divalent Cation Dependency, and Comparison with Anti-S-adenosylhomocysteine Antibody
2000
Diagnosis of Snakebite and the Importance of Immunological Tests in Venom Research
2014
Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling
2007
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Guidelines for the management of hemophilia
2012 Standout
Works of M Debray being referenced
Diet deficient in alpha-linolenic acid alters fatty acid composition and enzymatic properties of Na+, K+-ATPase isoenzymes of brain membranes in the adult rat
1999
Nutritional (n-3) polyunsaturated fatty acids influence the behavioral responses to positive events in mice
2000
Interspecies Scaling of Clearance and Volume of Distribution for Digoxin-Specific Fab
1996
Interspecies Scaling of Clearance and Volume of Distribution for Horse Antivenom F(ab′)2
1998
A puzzling case of transient global amnesia
2004
Association constants of monoclonal antibodies for hapten: heterogeneity of frequency distribution and possible relationship with hapten molecular weight
1994
Puromycin‐based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood–brain barrier‐specific properties
2005
[Excess antivitamin K in elderly hospitalised patients aged over 70. A one-year prospective survey].
2003
Effect of Antivenom on Venom Pharmacokinetics in Experimentally Envenomed Rabbits: Toward an Optimization of Antivenom Therapy
1997
Central nervous system involvement in Sjögren's syndrome: evidence from neuropsychological testing and HMPAO-SPECT.
1999
A Cross-over Pharmacokinetic Study of a Double Viral Inactivated Factor IX Concentrate (15 nm Filtration and SD) Compared to a SD Factor IX Concentrate
1998